Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date09 Feb 2003 |
100 Clinical Results associated with Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.
100 Deals associated with Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.